植物由来のワクチンの世界市場

植物由来のワクチンの世界市場は2030年までに15億米ドルに到達

2024年に1億4,080万米ドルと推定される植物由来のワクチンの世界市場は、分析期間2024-2030年にCAGR 47.8％で成長し、2030年には15億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである細菌ワクチンは、CAGR 43.0%を記録し、分析期間終了時には4億9,840万米ドルに達すると予測されます。ウイルスワクチン分野の成長率は、分析期間中CAGR 54.0%と推定されます。

米国市場は3,840万米ドルと推定、中国はCAGR 57.2％で成長予測

米国の植物由来のワクチン市場は、2024年には3,840万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGR 57.2%を牽引し、2030年には予測市場規模3億5,750万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中にそれぞれ40.8%と44.5%のCAGRで成長すると予測されています。欧州では、ドイツがCAGR約42.1%で成長すると予測されています。

世界の植物由来のワクチン市場- 主要動向と促進要因まとめ

植物はどのように次世代ワクチン生産プラットフォームに組み込まれているのか？

植物由来のワクチンはバイオ医薬品イノベーションのフロンティアであり、ヒトや動物に特異的な免疫反応を引き起こす免疫原性タンパク質を生産するバイオファクトリーとして植物が使用されています。これらのワクチンは、一般的にタバコ、レタス、ジャガイモなどの植物を遺伝子工学的に操作し、ウイルス抗原、細菌毒素、サブユニット断片などの組換えタンパク質を発現させることによって開発されます。このアプローチには、迅速なスケーラビリティ、室温での安定性、コンタミネーションのリスクを伴う動物由来成分や微生物発酵システムの排除など、いくつかの明確な利点があります。これらの特性は、コールドチェーン・インフラや無菌生産施設が限られていたり、利用できなかったりする、低資源やパンデミックに見舞われた環境において特に重要です。

アグロバクテリウムを介した形質転換やウイルスベクターシステムなど、植物分子農法における注目すべきブレークスルーは、植物細胞における標的抗原の収量と発現効率を著しく向上させました。メディカゴやケンタッキー・バイオプロセシングのような企業は、インフルエンザ、COVID-19、エボラ出血熱に対する植物由来ワクチンの実行可能性を実証し、いくつかの候補を臨床試験に進めています。さらに、植物由来のプラットフォームは、ウイルス様粒子（VLP）を生産することができます。VLPは、本来のウイルス構造を忠実に模倣し、感染性物質を運ぶことなく強力な免疫反応を刺激します。これらの技術革新により、植物ベースのシステムは、従来の卵や細胞培養をベースとしたワクチン製造法に代わる競争力のある選択肢として位置づけられています。

なぜ安全性、コスト、柔軟性が植物由来のワクチンに戦略的優位性を与えているのか？

植物由来のワクチンの最も強力な価値提案のひとつは、その良好な安全性プロファイルです。植物はヒトの病原体を保有しないため、哺乳類や昆虫の細胞株よりも本質的に安全です。動物由来の成分を排除することで、人獣共通感染症のリスクを減らし、アレルギー反応や自己免疫反応を軽減することができます。これらのワクチンはまた、細菌発酵系と比較してエンドトキシンが存在する可能性が低く、全体的な忍容性が向上します。規制の観点からは、こうした安全性の利点により、ワクチン製造パイプラインの多様化に熱心ないくつかの管轄区域における承認プロセスが合理化されています。

コスト効率も大きな利点です。従来のワクチン製造には、高価なバイオリアクター、厳格な無菌条件、長時間の細胞培養プロセスが必要でした。対照的に、植物ベースのシステムは、最小限の投入コストで高いバイオマス収量を提供し、温室や垂直農法セットアップを用いた迅速なスケールアップを可能にします。このため、特に低所得国や世界のワクチン供給チェーンへのアクセスが限られている地域では、パンデミック対策戦略にとって非常に魅力的です。さらに、植物発現プラットフォームはモジュール化されているため、遺伝子テンプレートの迅速な交換が可能であり、新たなウイルス変異体や新規病原体への迅速な対応が可能です。このような特性により、植物由来のワクチンは費用対効果が高いだけでなく、世界な予防接種プログラムに戦略的に適応することができます。

世界的にどのようなアプリケーションやパートナーシップが行われているのか？

植物由来ワクチン開発の最先端は、ヒトと獣医の両方の健康アプリケーションに集中しています。ヒトへの使用事例としては、インフルエンザ、COVID-19、ノロウイルス、ロタウイルスに対する予防薬があります。動物衛生分野では、家禽のニューカッスル病、家畜の口蹄疫、野生動物の狂犬病に対する植物由来のワクチンが開発されています。これらの動物用ワクチンは、規制上のハードルが低く、ヒトを対象としたワクチンの概念実証のための貴重な経路を提供しています。研究機関やバイオベンチャー企業は、開発期間を短縮するために、農業大学、政府保健機関、多国籍製薬企業との連携を強めています。

世界・パートナーシップは極めて重要な役割を果たしています。世界保健機関（WHO）とGaviは、植物ベースのプラットフォームを含む、分散型でコスト効率の高いワクチン生産モデルへの支持を表明しています。メディカゴがグラクソ・スミスクライン（GSK）とCOVID-19ワクチン候補で提携し、バイエルが植物由来医薬品を支援していることは、既存企業の信頼が高まっていることを示しています。新興経済諸国では、地域コンソーシアムが、風土病に対する地元でのワクチン開発に植物由来生産を活用し、医薬品の主権を高めています。このような戦略的提携は、規制の枠組みを改善し、資本を呼び込み、国境を越えた知識交換を促進しています。

何が植物由来のワクチン市場の世界的成長を加速させているのか？

世界の植物由来のワクチン市場の成長は、パンデミック後の世界における、迅速、柔軟、手頃な価格のワクチンプラットフォームの必要性など、いくつかの要因によって牽引されています。世界のCOVID-19危機は、従来のワクチン製造・流通システムにおける重大な脆弱性を露呈し、植物由来システムのような分散型でスケーラブルな製造方法への関心を呼び起こしました。パンデミックへの備えとワクチンの公平性が世界の政策優先事項となるにつれ、各国は国家バイオ医薬品戦略の一環として植物由来プラットフォームを模索しています。

現在進行中の研究開発のブレークスルー、新規生物製剤の規制当局による早期承認、投資家の関心の高まりが、複数の適応症におけるパイプラインの成長を後押ししています。気候の回復力、必要なインフラの少なさ、最小限のバイオセーフティリスクにより、植物由来のワクチンは特に遠隔地や資源の限られた環境での展開に適しています。さらに、遺伝子組換え果物や葉菜類を利用した経口ワクチンや食用ワクチンの可能性は、小児科の予防接種や集団予防接種キャンペーンを大きく変えるものとして検討されています。バイオセキュリティ、公平なアクセス、コスト抑制が世界的に重視される中、植物由来ワクチン市場は、従来のワクチンシステムに代わる破壊的かつ人道的な選択肢として、長期的な拡大が見込まれています。

セグメント

ワクチンタイプ（細菌ワクチン, Viral Vaccines, Parasite Vaccines, Other Vaccine Types）;供給源（Tobacco Plant, Maize, Potato, Other Sources）;用途（Influenza, COVID-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications）

調査対象企業の例（注目の合計42社）

• Agenus Inc.
• Akdeniz University
• Baiya Phytopharm Co., Ltd.
• Biodextris Inc.
• British American Tobacco PLC
• Calyxt Inc.
• Creative Biolabs Inc.
• ExpreS2ion Biotechnologies ApS
• Fraunhofer USA Inc.
• G+FLAS Life Sciences
• Icon Genetics GmbH
• iBio Inc.
• Kentucky BioProcessing Inc.
• LenioBio GmbH
• Medicago Inc.
• Panacea Biotec Limited
• PlantForm Corporation
• Transgene SA
• Ventria Bioscience
• Zyus Life Sciences Inc.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・業界団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストを含む1万4,949人のエコノミストを追跡しています。当社の16,491を超えるレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Plant-based Vaccines Market to Reach US$1.5 Billion by 2030

The global market for Plant-based Vaccines estimated at US$140.8 Million in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 47.8% over the analysis period 2024-2030. Bacterial Vaccines, one of the segments analyzed in the report, is expected to record a 43.0% CAGR and reach US$498.4 Million by the end of the analysis period. Growth in the Viral Vaccines segment is estimated at 54.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$38.4 Million While China is Forecast to Grow at 57.2% CAGR

The Plant-based Vaccines market in the U.S. is estimated at US$38.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$357.5 Million by the year 2030 trailing a CAGR of 57.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 40.8% and 44.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 42.1% CAGR.

Global Plant-Based Vaccines Market - Key Trends & Drivers Summarized

How Are Plants Being Engineered Into Next-Generation Vaccine Production Platforms?

Plant-based vaccines represent a frontier in biopharmaceutical innovation, wherein plants are used as biofactories to produce immunogenic proteins that trigger specific immune responses in humans or animals. These vaccines are developed by genetically engineering plants-commonly tobacco, lettuce, or potato-to express recombinant proteins such as viral antigens, bacterial toxins, or subunit fragments. The approach offers several distinct advantages: rapid scalability, room-temperature stability, and the elimination of animal-derived components or microbial fermentation systems that carry contamination risks. These attributes are particularly relevant in low-resource or pandemic-stricken settings where cold chain infrastructure and sterile production facilities are limited or unavailable.

Notable breakthroughs in plant molecular farming, including Agrobacterium-mediated transformation and viral vector systems, have significantly improved the yield and expression efficiency of target antigens in plant cells. Companies like Medicago and Kentucky BioProcessing have demonstrated the viability of plant-derived vaccines for influenza, COVID-19, and Ebola, advancing several candidates into clinical trials. Additionally, plant-based platforms can produce virus-like particles (VLPs), which closely mimic native viral structures and stimulate strong immune responses without carrying infectious material. These innovations are positioning plant-based systems as competitive alternatives to traditional egg- or cell-culture-based vaccine production methods.

Why Are Safety, Cost, and Flexibility Giving Plant-Based Vaccines a Strategic Advantage?

One of the strongest value propositions of plant-based vaccines is their favorable safety profile. Plants do not harbor human pathogens, making them inherently safer than mammalian or insect cell lines. The elimination of animal-derived components reduces the risk of zoonotic contamination and mitigates allergic or autoimmune responses. These vaccines also carry a lower likelihood of endotoxin presence compared to bacterial fermentation systems, improving overall tolerability. From a regulatory standpoint, these safety benefits are streamlining the approval process in several jurisdictions that are eager to diversify their vaccine manufacturing pipelines.

Cost-efficiency is another significant advantage. Traditional vaccine production requires expensive bioreactors, stringent aseptic conditions, and prolonged cell culture processes. In contrast, plant-based systems offer high biomass yields with minimal input costs, enabling rapid scale-up using greenhouses or vertical farming setups. This makes them highly attractive for pandemic preparedness strategies, especially in low-income countries or regions with limited access to global vaccine supply chains. Moreover, the modularity of plant expression platforms allows rapid swapping of genetic templates, enabling quick response to emerging viral variants or novel pathogens. These characteristics make plant-based vaccines not only cost-effective but strategically adaptable for global immunization programs.

Where Are the Leading Applications and Partnerships Taking Shape Globally?

The leading edge of plant-based vaccine development is concentrated in both human and veterinary health applications. Human use cases have included prophylactics against influenza, COVID-19, norovirus, and rotavirus. In the animal health space, plant-based vaccines have been developed for Newcastle disease in poultry, foot-and-mouth disease in livestock, and rabies in wild animals. These veterinary applications benefit from fewer regulatory hurdles and have provided a valuable proof-of-concept pathway for human-targeted vaccines. Research institutions and biotech startups are increasingly collaborating with agricultural universities, government health agencies, and multinational pharmaceutical companies to accelerate development timelines.

Global partnerships are playing a pivotal role. The World Health Organization and Gavi have expressed support for decentralized, cost-efficient vaccine production models, including plant-based platforms. Medicago’s collaboration with GlaxoSmithKline (GSK) for a COVID-19 vaccine candidate and Bayer’s support for plant-based pharmaceuticals indicate growing confidence from established players. In emerging economies, regional consortia are leveraging plant-based production to develop local vaccines against endemic diseases, boosting pharmaceutical sovereignty. These strategic alliances are improving regulatory frameworks, attracting capital, and promoting cross-border knowledge exchange-all of which are critical for the mainstreaming of plant-derived vaccine technology.

What’s Accelerating the Global Growth of the Plant-Based Vaccines Market?

The growth in the global plant-based vaccines market is driven by several factors, including the need for rapid, flexible, and affordable vaccine platforms in a post-pandemic world. The global COVID-19 crisis exposed significant vulnerabilities in traditional vaccine manufacturing and distribution systems, sparking interest in decentralized, scalable production methods like plant-based systems. As pandemic preparedness and vaccine equity gain global policy priority, countries are exploring plant-based platforms as part of their national biopharma strategies.

Ongoing R&D breakthroughs, regulatory fast-tracking for novel biologics, and growing investor interest are fueling pipeline growth across multiple indications. Climate resilience, low infrastructure requirements, and minimal biosafety risks make plant-based vaccines especially suitable for deployment in remote or resource-limited settings. Additionally, the potential for oral or edible vaccines-using transgenic fruits or leafy greens-is being explored as a game-changer for pediatric immunization and mass vaccination campaigns. With increasing global emphasis on biosecurity, equitable access, and cost containment, the plant-based vaccine market is poised for long-term expansion as a disruptive and humanitarian-aligned alternative to conventional vaccine systems.

SCOPE OF STUDY:

The report analyzes the Plant-based Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Vaccine Type (Bacterial Vaccines, Viral Vaccines, Parasite Vaccines, Other Vaccine Types); Source (Tobacco Plant, Maize, Potato, Other Sources); Application (Influenza, Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Agenus Inc.
• Akdeniz University
• Baiya Phytopharm Co., Ltd.
• Biodextris Inc.
• British American Tobacco PLC
• Calyxt Inc.
• Creative Biolabs Inc.
• ExpreS2ion Biotechnologies ApS
• Fraunhofer USA Inc.
• G+FLAS Life Sciences
• Icon Genetics GmbH
• iBio Inc.
• Kentucky BioProcessing Inc.
• LenioBio GmbH
• Medicago Inc.
• Panacea Biotec Limited
• PlantForm Corporation
• Transgene SA
• Ventria Bioscience
• Zyus Life Sciences Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Plant-based Vaccines - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Focus on Scalable, Cost-Effective Vaccine Manufacturing Spurs Interest in Plant-Based Vaccine Platforms
  • Expansion of Molecular Farming Capabilities Throws the Spotlight on Transgenic and Virus-Like Particle (VLP) Production
  • Innovation in Tobacco, Lettuce, and Alfalfa-Based Expression Systems Enhances Yield and Antigen Stability
  • Growth in Zoonotic and Emerging Infectious Disease Surveillance Fuels Development of Rapid Response Plant Vaccines
  • Collaboration With Academia and Global Health Agencies Accelerates Clinical Research and Deployment
  • Increasing Need for Room-Temperature-Stable Vaccines Drives Investment in Cold Chain-Free Biologics
  • Development of Edible and Oral Vaccine Formats Expands Immunization in Resource-Limited Regions
  • Surge in Pandemic Preparedness and Biosecurity Funding Supports Investment in Alternate Vaccine Platforms
  • Participation in Regulatory and WHO-Prequalification Pathways Boosts Global Distribution Prospects
  • Advancements in Agroinfiltration and Gene Silencing Techniques Enhance Precision in Antigen Expression
  • Emphasis on Low Allergenicity and Safety Profiles Strengthens Suitability for Pediatric Use
  • Expansion of Plant-Derived Veterinary Vaccines Supports Cost-Sensitive Livestock Disease Control
  • Innovation in Rapid Antigen Switching Platforms Enables Faster Response to Mutating Pathogens
  • Growth in Interest in Personalized and Cancer Therapeutic Vaccines Expands Role of Plant-Based Carriers
  • Focus on Non-GMP Greenhouse and Vertical Farming Units Enhances Localized Biomanufacturing
  • Increasing Acceptance of Recombinant Protein Therapeutics Supports Trust in Plant-Based Modalities
  • Advances in Downstream Purification and Scalability Address Commercialization Barriers
  • Rise in Biodefense and Humanitarian Vaccine Programs Fuels Interest in Easily Deployable Plant-Based Alternatives
  • Global Harmonization of Biopharmaceutical Guidelines Strengthens Clinical Trial and Manufacturing Pathways
  • Entry Into Multi-Antigen and Combination Vaccine Development Expands Preventive and Therapeutic Applications
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Plant-based Vaccines Market Analysis of Annual Sales in US$ for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Plant-based Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Plant-based Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Plant-based Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Bacterial Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Bacterial Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Bacterial Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Viral Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Viral Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Viral Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Parasite Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Parasite Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Parasite Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Vaccine Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Vaccine Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other Vaccine Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Covid-19 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Covid-19 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Covid-19 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Zika Virus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Zika Virus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Zika Virus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Ebola Virus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Ebola Virus by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Ebola Virus by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Poultry Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Poultry Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Poultry Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Influenza by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Influenza by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Influenza by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Tobacco Plant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Tobacco Plant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Tobacco Plant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Maize by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Maize by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Maize by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Potato by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Potato by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Potato by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Other Sources by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Other Sources by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 46: World 15-Year Perspective for Other Sources by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• JAPAN
  • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• CHINA
  • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• EUROPE
  • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Plant-based Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Plant-based Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Plant-based Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• FRANCE
  • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 95: France Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• GERMANY
  • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 119: Italy Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 121: Italy 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 122: UK Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 128: UK Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 129: UK Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 130: UK 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 137: Spain Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Spain Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 139: Spain 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 146: Russia Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Russia Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 148: Russia 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Europe Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 157: Rest of Europe 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Plant-based Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Plant-based Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Plant-based Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Asia-Pacific Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 169: Asia-Pacific 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 176: Australia Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Australia Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 178: Australia 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• INDIA
  • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 179: India Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 185: India Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 186: India Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 187: India 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 194: South Korea Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 195: South Korea Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 196: South Korea 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Asia-Pacific Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Plant-based Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Plant-based Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Plant-based Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 215: Latin America Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Latin America Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 217: Latin America 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 224: Argentina Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Argentina Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 226: Argentina 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 233: Brazil Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Brazil Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 235: Brazil 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 242: Mexico Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Mexico Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 244: Mexico 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Latin America Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Latin America 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Plant-based Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Plant-based Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Plant-based Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 263: Middle East Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Middle East Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 265: Middle East 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 272: Iran Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Iran Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 274: Iran 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 281: Israel Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Israel Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 283: Israel 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Saudi Arabia Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 292: Saudi Arabia 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 299: UAE Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 300: UAE Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 301: UAE 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Middle East Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Middle East 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030
• AFRICA
  • Plant-based Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Plant-based Vaccines by Vaccine Type - Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Plant-based Vaccines by Vaccine Type - Percentage Breakdown of Value Sales for Bacterial Vaccines, Viral Vaccines, Parasite Vaccines and Other Vaccine Types for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Plant-based Vaccines by Application - Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Plant-based Vaccines by Application - Percentage Breakdown of Value Sales for Covid-19, Zika Virus, Ebola Virus, Poultry Disease, Other Applications and Influenza for the Years 2015, 2025 & 2030
  • TABLE 317: Africa Recent Past, Current & Future Analysis for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Africa Historic Review for Plant-based Vaccines by Source - Tobacco Plant, Maize, Potato and Other Sources Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
  • TABLE 319: Africa 15-Year Perspective for Plant-based Vaccines by Source - Percentage Breakdown of Value Sales for Tobacco Plant, Maize, Potato and Other Sources for the Years 2015, 2025 & 2030

IV. COMPETITION